Clinical Trial

A Research Study to See How Insulin Icodec Helps People With Type 1 Diabetes Control Their Blood Sugar

Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
The study will look at how well insulin icodec controls blood sugar levels in participants who have never used it before. Participants with type 1 diabetes (T1D) will be treated with insulin icodec as prescribed to by their doctor, in accordance with usual clinical practice. This study will last for about 22 to 30 weeks.
Protocol Amendment History 1 change
critical Trial status changed: Recruiting → Active, Not Recruiting 2026-06-06
Trial Details
NCT Number NCT07160816
Lead Sponsor Novo Nordisk A/S
Conditions Diabetes Mellitus, Type 1
Enrollment 245 participants
Start Date 2025-08-28
Primary Completion 2027-01-20 (estimated)
Study Completion 2027-01-20 (estimated)
Updated on ClinicalTrials.gov 2026-06-29